Company: HURA
Filing Date: 2025-08-12
Form Type: S-1
Source: 0001193125-25-179009
Chunk: 259

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-08-12
Form: S-1
Chunk 259
---
 | 2023$ |       |
| Research and development   |     |             | 187 |     |       |   451 |
| General and administrative |     |             | 420 |     |       | 1,039 |
|                            |     |             | 607 |     |       | 1,490 |

All of the stock option expense for the periods ended June 30, 2024, and 2023, has been recognized as additional paid in capital. The aggregate intrinsic value of stock options outstanding at June 30, 2024, was nil (2023 - nil) and the aggregate intrinsic value of stock options exercisable at June 30, 2024, was nil (2023 - nil). As of June 30, 2024, there was $ 322 in unrecognized compensation expense that will be recognized over the next 2.02 years.

The following table sets forth changes in unvested stock options under all plans:

| Unvested at June 30, 2022 |     | Number ofoptions(in thousands) |  84 |   |     | Weightedaverageexerciseprice$ | 51.23 |
|:--------------------------|:----|:-------------------------------|----:|:--|:----|:------------------------------|------:|
| Granted                   |     |                                |  78 |   |     |                               |  8.79 |
| Vested                    |     |                                | (44 | ) |     |                               | 48.53 |
| Unvested at June 30, 2023 |     |                                | 118 |   |     |                               | 24.12 |
| Granted                   |     |                                |  89 |   |     |                               |  4.66 |
| Vested                    |     |                                | (70 | ) |     |                               | 19.44 |
| Forfeited                 |     |                                | (31 | ) |     |                               |  8.26 |
| Unvested at June 30, 2024 |     |                                | 106 |   |     |                               | 15.57 |

The aggregate intrinsic value of unvested stock options at June 30, 2024 was nil (2023 - nil ). The unvested stock options have a remaining weighted average contractual term of 7.72 (2023 – 8.83 ) years.

Restricted stock units

On August